Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Felix Scholtes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Angewandte Chemie (International Ed. in English)|February 21, 2019
Inducing Enantioselectivity in a Dynamic Catalyst by Supramolecular InterlockingJan Felix Scholtes, Oliver Trapp
Chirality|October 25, 2019
Design and synthesis of a stereodynamic catalyst with reversal of selectivity by enantioselective self-inhibitionJan Felix Scholtes, Oliver Trapp
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 24, 2019
Enantioselectivity Induced by Stereoselective Interlocking: A Novel Core Motif for Tropos LigandsJan Felix Scholtes, Oliver Trapp
Expert Opinion on Therapeutic Patents|September 2, 2024
Trends in covalent drug discovery: a 2020-23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in FDA-approved drugsJan Felix Scholtes, Cristobal Alhambra, Philip A Carpino
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Angewandte Chemie (International Ed. in English)|February 21, 2019
Inducing Enantioselectivity in a Dynamic Catalyst by Supramolecular InterlockingJan Felix Scholtes, Oliver Trapp
Chirality|October 25, 2019
Design and synthesis of a stereodynamic catalyst with reversal of selectivity by enantioselective self-inhibitionJan Felix Scholtes, Oliver Trapp
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 24, 2019
Enantioselectivity Induced by Stereoselective Interlocking: A Novel Core Motif for Tropos LigandsJan Felix Scholtes, Oliver Trapp
Expert Opinion on Therapeutic Patents|September 2, 2024
Trends in covalent drug discovery: a 2020-23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in FDA-approved drugsJan Felix Scholtes, Cristobal Alhambra, Philip A Carpino
Pageof 1